论文信息 - Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents.

Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents.

[1] W. Boden,et al. Percutaneous revascularization for stable coronary artery disease: temporal trends and impact of drug-eluting stents. , 2010, JACC. Cardiovascular interventions.

[2] M. Hori,et al. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. , 2008, JACC. Cardiovascular interventions.

[3] D. Holmes,et al. The COURAGE trial in perspective , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4] Samin K. Sharma,et al. Comparison of Coronary Artery Stenting Outcomes in the Eras Before and After the Introduction of Drug-Eluting Stents , 2008, Circulation.

[5] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[6] K. Kent,et al. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. , 2008, The American journal of cardiology.

[7] John Bresnahan,et al. Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents , 2007, Circulation.

[8] R. Gibbons,et al. Coronary Revascularization: New Evidence, New Challenges , 2007, Annals of Internal Medicine.

[9] P. Teirstein,et al. The truth and consequences of the COURAGE trial. , 2007, Journal of the American College of Cardiology.

[10] S. Kaul,et al. COURAGE under fire: on the management of stable coronary disease. , 2007, Journal of the American College of Cardiology.

[11] The COURAGE trial: is there still a role for PCI in stable coronary artery disease? , 2007, Nature Clinical Practice Cardiovascular Medicine.

[12] B. Gersh,et al. Twenty-Five–Year Trends in In-Hospital and Long-Term Outcome After Percutaneous Coronary Intervention: A Single-Institution Experience , 2007, Circulation.

[13] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[14] Ralph D'Agostino,et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. , 2007, The New England journal of medicine.

[15] Johan Lindbäck,et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. , 2007, The New England journal of medicine.

[16] S. Pocock,et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.

[17] Marco Valgimigli,et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[18] P. Serruys,et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[19] David O. Williams,et al. Outcomes of 6906 Patients Undergoing Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents: Report of the DEScover Registry , 2006, Circulation.

[20] F. L. Lucas,et al. Temporal Trends in the Utilization of Diagnostic Testing and Treatments for Cardiovascular Disease in the United States, 1993–2001 , 2006, Circulation.

[21] Joseph P Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22] J. Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) , 2006, Journal of the American College of Cardiology.

[23] J. Ioannidis,et al. Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis , 2005, Circulation.

[24] E. Boersma,et al. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. , 2005, European heart journal.

[25] D. Baim,et al. Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials , 2004, Circulation.

[26] D. Holmes,et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. , 2004, American heart journal.

[27] Gregg W Stone,et al. One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial , 2004, Circulation.

[28] Charles L. Brown,et al. Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis , 2004, Circulation.

[29] Patrick W Serruys,et al. Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin-E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry , 2004, Circulation.

[30] B. Gersh,et al. Indications for Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention in Chronic Stable Angina: Review of the Evidence and Methodological Considerations , 2003, Circulation.

[31] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[32] J. Brophy,et al. Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis , 2003, Annals of Internal Medicine.

[33] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.

[34] R. Gibbons. ACC/AHA guideline for management of patients with chronic stable angina , 2003 .

[35] Lawrence Joseph,et al. Evidence for Use of Coronary Stents , 2003 .

[36] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[37] Ousa,et al. A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .

[38] The Time Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial , 2001, The Lancet.

[39] J. Brophy. Improved clinical outcome after widespread use of coronary-artery stenting in Canada. , 2000, The New England journal of medicine.

[40] J. Spinelli,et al. Improved clinical outcome after widespread use of coronary-artery stenting in Canada. , 1999, The New England journal of medicine.

[41] D. Waters,et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.

[42] RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial , 1997, The Lancet.

[43] N. Geller,et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.

[44] L Chiariello,et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. , 1997, The New England journal of medicine.

[45] H Yokoi,et al. Three-year follow-up after implantation of metallic coronary-artery stents. , 1996, The New England journal of medicine.

[46] W Rutsch,et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[47] P. Teirstein,et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[48] P. Hartigan,et al. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.